Viewing Study NCT00252733


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-04-23 @ 11:22 PM
Study NCT ID: NCT00252733
Status: COMPLETED
Last Update Posted: 2014-05-14
First Post: 2005-11-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Diabetic Retinopathy Candesartan Trials
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus, Insulin-Dependent View